PLAT and breast carcinoma: High serum levels of IL-6 correlate with poorer outcomes in breast cancer patients.14 The aim of this study was to compare the serum level of TPA, and IL-6 in women with breast cancer at various stages of the disease and to consider the usefulness of these tumor markers in evaluating the response to chemotherapy for these patients.